Navigation Links
XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
Date:10/16/2007

of Cardiology at the HELIOS Heart

Center in Siebgurg, Germany and principal investigator of the CUSTOM I and

II clinical trials, will review the results to date from Biolimus A9(R)

DES clinical trials and registries. Professor Grube will present two-year

results from the CUSTOM I clinical trial and one-year results from the

CUSTOM II clinical trial.

Bernard de Bruyne, M.D. Ph.D, Cardiovascular Center, OLV Hospital in

Aalst, Belgium, will provide an overview of the Custom NX technology in a

presentation titled "XTENT Custom NX DES Systems: A Novel Approach to the

Percutaneous Treatment of Coronary Artery Disease (CAD)."

Time/Location: 8:00-10:00 p.m. EDT; Renaissance Washington, D.C. Hotel,

Grand Ballroom, 999 Ninth Street NW

Monday, October 22

Event: Analyst Webcast and Teleconference on CUSTOM I and CUSTOM II Data

XTENT will host a webcast and teleconference call to review the CUSTOM I

and CUSTOM II data presented on Sunday. The teleconference and slide

presentation can be accessed via the investor relations section of the

company's website at http://investor.xtentinc.com/events.cfm or by calling

888-663-2258 (from the U.S.), 913-312-1277 (international). Please dial in

or access the website five to ten minutes prior to the beginning of the

call. The webcast will be archived on the website for a minimum of three

months, and can be accessed at the investor relations portion of the

company's website at http://investor.xtentinc.com

Time/Location: 7:00 a.m. EDT

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of
'/>"/>

SOURCE XTENT, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
2. The Past, Present and Future of HLA Typing
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 ... healthcare funding changes brought about by the ... both reimbursement and prescribing of pharmaceutical therapies. ... (MCOs) cover beneficiaries through new regulations and ... is occurring in the health exchanges—state-based marketplaces ...
(Date:7/31/2014)... Portugal , July 31, 2014 ... Cork, Ireland has successfully passed a pre-approval inspection ... The inspection, carried out by the FDA Consumer Safety Officer, ... planned, started on 21 st July and concluded on ... be compliant with the principles and guidelines of Good Manufacturing ...
(Date:7/31/2014)...  Zacks.com announces the list of stocks featured in the ... the latest news and events impacting stocks and the financial ... BIIB - Free Report ), Gilead (Nasdaq: GILD ... Free Report ), AbbVie (NYSE: ABBV - Free Report ... Today, Zacks is promoting its ,Buy, stock recommendations. ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6
... SHAWNEE, Kan., June 17, 2011 Bayer HealthCare LLC ... of the lawsuit between Bayer and Farnam Companies Inc. ... tick control products.  As part of the settlement, Farnam ... Farnam,s print and online advertising campaign included claims that ...
... 17, 2011 NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank, CEO, received the ... 2011 New England Award in the Medical Devices category. ... extraordinary success in such areas as innovation, financial performance ...
Cached Medicine Technology:Bayer Announces Farnam Companies' Agreement to Halt Disputed Bio Spot® Ads 2NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 2NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 3NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 4
(Date:7/31/2014)... Cosmetic Town has introduced a secure verification ... will be able to verify their patients before the ... guarantees their authenticity. This will help prospective patients ... information that has been verified to come from a ... Town to filter out fake patients who leave fraudulent ...
(Date:7/31/2014)... 2014 NEWwoodworks, fine woodworking group at ... brand presence with a website dedicated to highlighting their ... has specialized in handcrafted cabinetry, furniture, stairs , ... earned a reputation for taking on the remarkable, challenging ... commonly craft with reclaimed wood, often using near extinct ...
(Date:7/31/2014)... July 31, 2014 US Hair Restoration Founder, ... now be known as Parsa Mohebi Hair Restoration. Since ... of patients in Southern California and around the world, who ... Hills and Orange County. These patients achieved the full benefits ... techniques that were perfected by Dr. Mohebi. They have ...
(Date:7/31/2014)... Daily Gossip indicates in its "Neuropathy Miracle" review ... problem. However, this is not a solution. , The ... Peter Bansby, who decided to reveal his method with ... world find a unique way of overcoming their health ... and cons from a full Neuropathy Miracle review, simply ...
(Date:7/31/2014)... 31, 2014 July 31, 2014- Title Boxing ... celebrate they have launched a Facebook Sweepstakes giving away prizes ... you have to do is visit http://www.facebook.com/titleboxingcoolsprings and ... share with your friends, and for each one that enters, ... “We are so excited to bring such a new and ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town Improves Patient Experience Through Secure Verification of Patients and Doctors 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:US Hair Restoration Becomes Parsa Mohebi Hair Restoration 2Health News:Neuropathy Miracle Review Reveals Peter Bansby's Unique Cure Method 2
... , , WEDNESDAY, May 28 (HealthDay News) -- Two new ... , Almost 15 percent of Americans are constipated at any ... of two reports in the May 29 issue of the ... on the efficacy of the experimental drug prucalopride on 620 ...
... N.Y., May 28 Caribbean People,International Collective Inc (CPIC) ... community event is set for Sunday, June 8th 2008--Caribbean,American ... opening,sunrise ceremony at 9:30 A.M. and then will kick ... at 10:15 A.M. The 5 K Walk will,continue throughout ...
... Sanaa Lathan Celebrates Inspirational Stories of how People ... ENGLEWOOD CLIFFS, N.J., May 28 Skin is,amazing: it covers ... a,symbol of pride, for others it,s a canvas to tell ... to be honored. Skin means something different,to almost everyone you ...
... ANGELES, May 28 Dr. Jeffrey Cummings, Medical,Director ... at UCLA,received the prestigious Ronald and Nancy Reagan ... team devote themselves to, discovering new,treatments and methods ... disorders., In his speech of acceptance at ...
... a world of internet savvy,patients and consumers, everyday tasks ... With a few clicks of the mouse, your patient,can ... even buy,groceries! A patient,s experience with their dentist is ... friendly., With the new Smile Dash Patient Portal ...
... It could mean development of new class of drugs, ... new compound that inhibits HIV protease has been developed by ... which is necessary for HIV replication, is a common target ... first new HIV protease inhibitor compound to be developed in ...
Cached Medicine News:Health News:Two Drugs Show Promise Against Severe Constipation 2Health News:Two Drugs Show Promise Against Severe Constipation 3Health News:Caribbean People International Collective Inc to Host 8th Annual AIDS WALK CARIBBEAN 2Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 2Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 3Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 4Health News:Empowering Your Patients: Smile Dash Portal 'Bridges Gap' Between Dentists and Patients 2Health News:New Compound Slows HIV Replication 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: